Cognos Therapeutics Corp., an advanced medical device company focused on creating unique technologies to radically advance the diagnosis and treatment of neuropathic diseases, has signed a letter of engagement with Maxim Group LLC. According to the agreement, Maxim will provide financial advisory and investment banking services to Cognos; the services will also include support in identifying and evaluating merger and acquisition opportunities. “We are incredibly pleased to launch this relationship with Maxim,” said Cognos CEO Frank Adell in the press release. “We believe Maxim can assist us in pursuing strategic growth and in building long-term value for our shareholders. . . . Our goal is that this will further enable us to focus on our product, the Sinnais, a standalone, implantable smart pump. This closed-loop, MRI-compatible medical device is designed to deliver therapeutic drugs locally and metronomically to a desired area. Specifically, our focus is on delivering drugs into the neuro region. Sinnais has full wireless communication capability and compatibility with the cloud.”
To view the full press release, visit https://nnw.fm/gQb2U
About Cognos Therapeutics Inc.
Cognos Therapeutics is an advanced medical device company focused on creating unique technologies to radically advance the diagnosis and treatment of neuropathic diseases, including tumor-based brain and spinal cancers, degenerative cognition disorders such as Alzheimer’s and Parkinson’s disease, and cerebral trauma occurrences such as epilepsy and stroke, as well as other central nervous system afflictions. For more information about the company, visit www.CognosThx.com.
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.networknewswire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
[email protected]
NetworkNewsWire is part of the InvestorBrandNetwork
